Table of Content


Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4 Market Breakdown by Drug Type
4.1 Market by Drug Type
4.2 Ketamine
4.3 Gamma-hydroxybutyric Acid (GHB)
4.4 Others
Chapter 5 Market Breakdown by Application
5.1 Market, by Application
5.2 Resistant Depression and Anxiety
5.3 Opiate Addiction
5.4 Post-Traumatic Stress Disorder
5.5 Narcolepsy
5.6 Others
Chapter 6 Market Breakdown by Region
6.1 Global Market, by Region
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Psychedelic Drugs and Precision Medicine
Chapter 8 Industry Structure
8.1 Company Rankings
8.2 Recent Key Developments
Chapter 9 Company Profiles
CELON PHARMA S.A.
CYBIN CORP.
HIKMA PHARMACEUTICALS PLC.
JAZZ PHARMACEUTICALS INC.
MIND MEDICINE INC.
PFIZER INC.
PHARMATHER HOLDINGS LTD.
REVIVE THERAPEUTICS LTD.
Chapter 10 Project Scope and Methodology
10.1 Scope of Report
10.2 Methodology
10.3 Analyst’s Credentials
 



List of Figures


Summary Figure A : Global Market Shares of Psychedelic Drugs, by Region, 2021
Summary Figure B : Growth Rates of the North American, European and Asia-Pacific Markets for Psychedelic Drugs, 2022–2027
Figure 1 : Global Market Shares of Psychedelic Drugs, by Drug Type, 2021
Figure 2 : Global Market Shares of Psychedelic Drugs, by Application, 2021
Figure 3 : Global Market for Psychedelic Drugs, by Region
Figure 4 : Global Market Shares of Psychedelic Drugs, by Region, 2021

List of Tables

 

Summary Table : Global Market for Psychedelic Drugs, by Region, Through 2027
Table 1 : Global Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 2 : Global Market for Psychedelic Drugs, by Application, Through 2027
Table 3 : Global Market for Psychedelic Drugs, by Region, Through 2027
Table 4 : North American Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 5 : North American Market for Psychedelic Drugs, by Application, Through 2027
Table 6 : European Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 7 : European Market for Psychedelic Drugs, by Application, Through 2027
Table 8 : Asia-Pacific Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 9 : Asia-Pacific Market for Psychedelic Drugs, by Application, Through 2027
Table 10 : RoW Market for Psychedelic Drugs, by Drug Type, Through 2027
Table 11 : RoW Market for Psychedelic Drugs, by Application, Through 2027
Table 12 : Ranking of Psychedelic Drug Companies, 2021
Table 13 : Recent Key Developments in the Global Market for Psychedelic Drugs
Table 14 : Celon Pharma: Products
Table 15 : Cybin Corp.: Pipeline Products
Table 16 : Hikma Pharmaceuticals: Products
Table 17 : Jazz Pharmaceuticals Inc.: Products
Table 18 : Mind Medicine: Pipeline Products
Table 19 : Pfizer Inc.: Product
Table 20 : PharmaTher Holdings Ltd.: Pipeline Product